Contact
Please use this form to send email to PR contact of this press release:
Capricor Therapeutics Announces Key Regulatory Updates for its Duchenne Muscular Dystrophy Program
TO:
Please use this form to send email to PR contact of this press release:
Capricor Therapeutics Announces Key Regulatory Updates for its Duchenne Muscular Dystrophy Program
TO: